NUGO
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Sept 2023)
What this means for you
This application is over — abandoned 18 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88796516
- Mark type
- Stylized text
- Filed
- 13 Feb 2020
- Published for opposition
- 23 Jun 2020
- Abandoned
- 18 Sept 2023
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the fields of pain relief, prevention, management and treatment; veterinary preparations in the fields of pain relief, prevention, management and treatment
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical field; consulting services in the field of pharmaceutical research and development; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- CENTREXION THERAPEUTICS CORPORATION, BOSTON, MA, US
- CENTREXION THERAPEUTICS CORPORATION, BOSTON, MA, US
Prosecution history
- 11 Mar 2026 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 18 Sept 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Sept 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2023 — SOU EXTENSION 5 GRANTED
- 17 Feb 2023 — SOU EXTENSION 5 FILED
- 03 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Aug 2022 — SOU EXTENSION 4 GRANTED
- 17 Aug 2022 — SOU EXTENSION 4 FILED
- 17 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2022 — SOU EXTENSION 3 GRANTED
- 18 Feb 2022 — SOU EXTENSION 3 FILED